Navigation Links
C8 Lawsuit Filed By Wright & Schulte LLC on Behalf of Ohio Woman Stricken with Thyroid Cancer Allegedly Due to C8 Tainted Drinking Water
Date:8/18/2013

Columbus, OH (PRWEB) August 19, 2013

The C8 lawsuit lawyers at Wright & Schulte LLC announce that they have filed a C8 lawsuit on behalf of an Ohio woman who developed thyroid disease and thyroid cancer, allegedly due to exposure to drinking water contaminated with C8, a toxic chemical discharged from DuPont’s Washington Works Plant in Parkersburg, West Virginia. The C8 lawsuit, which was filed on August 8, 2013, in U.S. District Court, Southern District of Ohio, further alleges that the Plaintiff was caused to sustain severe and permanent personal injuries, pain, suffering, and emotional distress due to DuPont’s negligence. (2:13-cv-00792- JLG-TPK)

Wright & Schulte LLC continues to offer free C8 lawsuit consultations to anyone who may have been exposed to C8 tainted drinking water associated with the DuPont facility. Individuals who lived or worked in certain Ohio and West Virginia water districts prior to December 3, 2004, or their survivors, may be entitled to file a C8 lawsuit for personal injury or wrongful death if they or their loved one suffered from an illness that may be linked to C8 exposure, including:

  •     Kidney cancer
  •     Testicular cancer
  •     Thyroid disease
  •     Inflammatory bowel disease (ulcerative colitis)
  •     Preeclampsia (high blood pressure during pregnancy)
  •     High cholesterol

For more information on filing a C8 lawsuit, or to arrange for a free legal consultation with an attorney from Wright & Schulte LLC, please visit yourlegalhelp.com. Follow Wright & Schulte's C8 Facebook page for all current news and information regarding C8 water contamination and C8 lawsuits.

C8 is a chemical used in the manufacture of Teflon, and was discharged from the Washington Works plant for decades. This latest C8 lawsuit filed by Wright & Schulte LLC is one of dozens of similar complaints pending in a multidistrict litigation established in the Southern District of Ohio for claims filed in accordance with the 2005 C8 class action lawsuit settlement. That accord, which DuPont reached with 70,000 people who lived and worked in the vicinity of the Washington Works facility, held that anyone who had been exposed to C8 contaminated water would be eligible to file a personal injury lawsuit if they developed a disease ultimately determined to be associated with C8 exposure. To qualify to file an individual C8 lawsuit, potential plaintiffs must have been diagnosed with a related diseased, and they must have lived in one of six water districts stipulated by the settlement prior to December 3, 2004. Those six water districts are:

  •     Little Hocking, Ohio
  •     Belpre, Ohio
  •     Village of Pomeroy, Ohio
  •     Tuppers Plains, Ohio
  •     Lubeck Public Service District, West Virginia
  •     Mason County Public Service District, West Virginia
(Leach v. E.I. Du Pont De Nemours & Co., No. 01-C-608 (W. Va. Cir. Ct.))

In October 2012, the C8 Science Panel announced it had found probable links between the chemical and a number of disorders, including testicular and kidney cancers, pregnancy-induced hypertension (pre-eclampsia), thyroid disease, high cholesterol and inflammatory bowel disease.
(c8sciencepanel.org/)

According to court documents, the U.S. Judicial Panel on Multidistrict Litigation issued an order in April 2013 that transferred all federal C8 lawsuits alleging personal injury or wrongful death to the Southern District of Ohio for consolidated pretrial proceedings. Wright & Schulte LLC partner, Richard W. Schulte, has been appointed to the Plaintiffs’ Steering Committee in the federal litigation. All of the C8 lawsuits pending in the multidistrict litigation allege that DuPont had information in its possession as early as the 1980s that indicated exposure to C8-tainted drinking water could lead to various adverse health consequences in exposed workers. Plaintiffs further allege that DuPont has known for several decades that discharge of C8 into the Ohio River from the Washington Works contaminated water supplies, and that C8 pollution from the facility could be reduced substantially by use of a carbon absorption treatment system. (In Re: E.I. DuPont De Nemours and Company C-8 Personal Injury Litigation, MDL No. 2433)

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free DuPont C8 lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

Read the full story at http://www.prweb.com/releases/2013/8/prweb11038094.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
2. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
3. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
4. New Lawsuit Alleges Teen Molestation by Ex-Deputy
5. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
6. New Lawsuit on Propecia: Severe Adverse Events
7. New Lawsuit on Accutane Crohn’s Disease: Severe Adverse Events
8. New Lawsuit alleges Actos caused Bladder Cancer
9. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
10. Wright & Schulte File Skechers Lawsuit on Behalf of Ohio Woman Who Fell, Suffered Broken Wrist Allegedly Due to Use of Skechers Shape-Ups
11. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel carrier that services the ... Eastern Michigan last Friday in order to aid in the Flint water crisis. In ... a facility located in Clio, only 15 miles away from Flint. , “We have ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand ... within Healthcare, recently partnered with Heart City Health Center to improve ... 23 years, Heart City Health Center has provided the Elkhart community with access ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... 10 ... Brand. There were three leading bottled water brand owners that topped the list as ... enhance connectivity and optimize conversion. The premier brand was Tibet 5100, a top notch ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged to ... shows that the Goal Attainment Scale (GAS) captures 20% more change in outcomes ... more about the Goal Attainment Scale, Education Resources Inc. is offering a course ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... and PITTSBURGH, Feb. 10, 2016 Mylan N.V. (NASDAQ, ... quarter and year ended December 31, 2015. ... Full year adjusted total revenues of $9.45 billion, up ... year; GAAP total revenues of $9.43 billion. Excluding the ... markets specialty and branded generics business (the "EPD Business"), ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: